Advanced prosthetic designs and OEM/ODM solutions engineered to optimize clinical outcomes and restore biomechanical mobility.
Synoviq Medical Technology (China) Co., Ltd. represents the cutting edge of domestic orthopedic implant fabrication, exporting to multi-continental destination markets.
Synoviq Medical Technology (China) Co., Ltd. is a professional manufacturer of orthopedic implants and surgical instruments, dedicated to delivering innovative, reliable, and high-quality medical solutions for healthcare professionals worldwide. Since its establishment, Synoviq has focused on research, development, precision manufacturing, and international quality standards, providing comprehensive OEM and ODM services for global medical device brands, distributors, and hospitals.
Our product portfolio includes trauma fixation systems, spinal implants, locking plates, intramedullary nails, external fixation systems, orthopedic screws, surgical instruments, and customized orthopedic solutions. Equipped with advanced CNC machining centers, precision inspection equipment, and modern clean production facilities, we ensure every product meets strict international quality requirements.
Driven by continuous innovation, Synoviq invests heavily in R&D and intelligent manufacturing to enhance product performance, surgical efficiency, and patient outcomes. Our experienced engineering team works closely with customers to develop customized products tailored to different clinical applications and market demands.
With a customer-oriented philosophy, competitive pricing, stable supply capability, and efficient technical support, Synoviq has established long-term partnerships with distributors, medical brands, and healthcare organizations across Europe, North America, South America, the Middle East, and Asia-Pacific. Committed to quality, innovation, and global collaboration, Synoviq Medical Technology (China) Co., Ltd. strives to become a trusted international partner in the orthopedic medical device industry.
| Item | Information Details |
|---|---|
| Company Name | Synoviq Medical Technology (China) Co., Ltd. |
| Brand | Synoviq |
| Established | March 18, 2016 |
| Building Area | 18,600 m² |
| Annual Export Revenue | USD 21.8 Million |
| Export Experience | 8 Years |
| Industry Experience | 14 Years |
| Quality Inspection | 100% Final Inspection & Incoming Material Inspection |
| Product Inspection Methods | CMM Measurement, Mechanical Testing, Surface Roughness Testing, Hardness Testing, Salt Spray Testing, Sterility Validation |
| Quality Control Staff | 48 |
| Business Type | Manufacturer & Exporter (OEM/ODM) |
| Main Markets | Europe, North America, South America, Middle East, Southeast Asia |
| Supply Chain Partners | 1,120+ |
| Main Customer Types | Medical Device Brands, Importers, Distributors, Hospitals, Government Procurement Projects |
| R&D Capability | Independent Product Design, Prototype Development, Clinical-Oriented Engineering, OEM & ODM Development |
| Customization Options | Logo Customization, Packaging Customization, Product Design Customization, Material Selection, Surface Treatment |
| New Products Released Last Year | 186 |
| R&D Engineers | 76 |
Understanding the clinical, economical, and regulatory variables that define high-volume joint replacement procurement.
The global orthopedics market is undergoing structural shifts driven by aging populations, expansion of health insurance coverage in developing economies, and strict budgetary controls within public hospital systems. Importers and medical device brands must balance the clinical pressure for low revision rates with the economic pressure of cost-containment. Sourcing Class III implants requires partnering with manufacturers capable of maintaining absolute batch-to-batch consistency. Our factory provides optimized supply strategies to counter logistic disruptions, ensuring that critical joint replacement kits—comprising femoral stems, acetabular cups, liners, femoral heads, and associated instrumentation—are delivered on time under cleanroom-certified packaging.
In Total Hip Arthroplasty (THA) and Total Knee Arthroplasty (TKA), tribology—the study of friction, wear, and lubrication—is paramount. The wear of UHMWPE (Ultra-High-Molecular-Weight Polyethylene) liners against femoral heads can lead to osteolysis and subsequent aseptic loosening. To address this clinical risk, we employ advanced titanium alloys (Ti-6Al-4V ELI) and cobalt-chromium-molybdenum (CoCrMo) alloys, pairing them with highly cross-linked polyethylene (HXLPE) or BIOLOX-grade ceramics. Our coatings, including Vacuum Plasma Sprayed (VPS) Titanium and Hydroxyapatite (HA) biomimetic coatings, accelerate osseointegration, providing robust biological secondary fixation that extends implant survival rates beyond the standard 15-year lifecycle threshold.
Ensuring zero defects in orthopedic implants requires an unbroken chain of precision. Our workflow integrates state-of-the-art multi-axis CNC milling, high-precision Swiss-type lathes, automatic grinding, and laser marking within ISO Class 7/Class 10,000 cleanrooms. Regulatory validation under CE Class III and ISO 13485 involves thorough evaluation methods: Coordinate Measuring Machines (CMM) for dimensional verification, metallographic analysis for raw materials, roughness testing to ensure optimized joint interfaces, and sterility validation. This industrial configuration minimizes micro-motion, guarantees component modularity compatibility, and provides the foundation for our global hospital and distributor networks.
View our comprehensive processing steps and advanced testing systems inside the Synoviq medical production park.
Adapting to digital surgery ecosystems, advanced biocompatibility, and patient-specific matching.
The next decade of joint arthroplasty belongs to personalized healthcare and computational synergy. As an progressive manufacturer, Synoviq is currently executing an advanced R&D roadmap designed to integrate technology closely into manufacturing routines. Key development sectors include:
Reducing registration friction and maintaining compliance across global regulatory systems.
Acquiring market clearance for Class III surgical implants requires transparent documentation and adherence to global regulatory standards. Synoviq supports its global distribution channels by offering detailed technical files, including Biocompatibility Reports (ISO 10993), Clinical Evaluation Reports (CER), and Sterilization Validation reports (ISO 11137 / ISO 11135). We assist partners during regulatory submissions to health authorities, including EMA (CE marking), FDA (510k), and local ministries of health in Latin America, APAC, and the Middle East.
Additionally, our local sales support services include surgical training instrumentation kits (reusable drills, trials, reamers, inserters), which allow orthopedic surgeons to familiarize themselves with the Synoviq system mechanics, optimizing clinical confidence and patient outcomes.
Answering regulatory, engineering, and commercial sourcing inquiries for orthopedic implants.
Complementary equipment, veterinary-specific hip replacements, and surgical tool kits.